DLA Piper advised Sensible Biotechnologies, a developer of a first-of-its-kind integrated platform for the design, optimization and cell-based manufacturing of naturally modified mRNA, on its Series A financing led by Oxford Science Enterprises. Read now: spr.ly/6019BGFiql https://t.co/XmLXKnZ9V3

Our latest issue of Intellectual Property News explores key developments in franchise noncompetes, patent marking requirements for settlement licenses, and inherent trademark strength in likelihood-of-confusion disputes. Read more: spr.ly/6014BGFgvo https://t.co/HybbdHgU3R

DLA Piper is proud to recognize the recipients of our 2026 Americas Pro Bono Awards. This year's honorees have worked to expand access to justice for individuals and families, support immigrants and asylum seekers, and advocate for vulnerable children. Their work has also focused on environmental and sustainability initiatives, strengthening nonprofit organizations, protecting wildlife conservation efforts, and helping communities access critical public benefits. DLA Piper is also pleased to present its inaugural Pro Bono Lifetime Achievement Award to Of Counsel Kenneth Schmetterer. Throughout his career, Ken has dedicated substantial time to matters involving prisoners' rights, reentry, youth defense, clemency, civil rights, and education equality. His commitment to service, mentorship, and access to justice has created lasting impact. Please join us in congratulating this year’s award recipients. Learn more about our pro bono work: dlapiper.com/en-us/about-us…